Trial intelligence / Profile preview

Tranexamic Acid vs Adrenaline for Endobronchial Bleeding

NCT04771923Completed

Sponsor
Clinical Hospital Center Zagreb
Start
Feb 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid in hemoptysis (2 arms), sponsored by Clinical Hospital Center Zagreb. Primary endpoint: Percentage of successfully controlled iatrogenic endobronchial bleeding. Started Feb 2021; status: completed.

02

Drugs

tranexamic acid
03

Conditions

hemoptysis

Beyond the preview

Go deeper on NCT04771923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04771923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call